The protein expression level was remarkably similar between healthy controls and patients with NEDAMSS with an exception for the adult patient cell line, containing the Arg188* variant, which displayed a significant reduction in the expression level of full-length IRF2BPL. The gene discussed is IRF2BPL; the disease is neurodevelopmental disorder with regression, abnormal movements, loss of speech, and seizures.